Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]
A Phase 2 trial evaluating MEC chemotherapy (mitoxantrone, etoposide, cytarabine) with lenalidomide for relapsed or refractory acute myeloid…
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Evaluate Efficacy and Safety/Tolerability Profiles of Antroquinonol in Acute Myeloid Leukemia (AML) Adult Patients [Phase 2]
Phase 2 clinical trial evaluating antroquinonol for efficacy and safety/tolerability in adults with acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Prospective Study of Mylotarg and G-CSF in Acute Myeloid Leukemia Treatment [Phase 2]
A Phase 2 prospective study evaluating Mylotarg (gemtuzumab ozogamicin) with G-CSF in Novo Acute Myeloid Leukemia has completed with posted …
-
CLINICAL_TRIALS trial_result · 2021-01-26Clinical Trial Update: Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia [Phase 2]
Phase 2 clinical trial evaluating busulfan, fludarabine, and clofarabine conditioning followed by allogeneic stem cell transplantation in pa…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Stem Cell Transplant for Hematological Malignancy [NA]
Clinical trial update on stem cell transplantation for hematologic malignancies; status terminated with results posted in 2021.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-01-19Clinical Trial Update: IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome [Phase 3]
Phase 3 trial evaluating intravenous busulfan with allogeneic hematopoietic stem cell transplant for patients with myelodysplastic syndrome …
-
CLINICAL_TRIALS trial_result · 2021-01-14Clinical Trial Update: CPX-351 in Treating Patients With Newly Diagnosed, High-Risk Acute Myeloid Leukemia [Phase 2]
Phase 2 clinical trial of CPX-351 (Vyxeos) for newly diagnosed high-risk acute myeloid leukemia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-14Clinical Trial Update: SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction [Phase 3]
Phase 3 clinical trial update on SGI-110 (guadecitabine) in adults with untreated acute myeloid leukemia who are not candidates for intensiv…
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor [Phase 2]
Phase 2 trial evaluating two doses of ATIR101 (T-lymphocyte enriched, host alloreactive T-cell depleted) in hematologic malignancy patients …
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor [Phase 2]
Phase 2 trial update on ATIR, donor T-lymphocytes depleted ex vivo of host alloreactive T-cells, in patients with hematologic malignancies p…
-
CLINICAL_TRIALS trial_result · 2020-12-31Clinical Trial Update: Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine [Phase 2]
Phase 2 trial evaluating induction therapy with idarubicin and etoposide followed by sequential or concurrent azacitidine and maintenance az…
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT [Phase 2, Phase 3]
Phase 2/3 clinical trial update on a Dec+Flu+Bu conditioning regimen for elderly AML patients undergoing allogeneic hematopoietic stem cell …
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML [Phase 2]
Phase 2 trial update evaluating cladribine in combination with CAG for efficacy and safety in newly diagnosed unfit patients with acute myel…
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: Combination of Quizartinib and Omacetaxine Mepesuccinate for AML Carrying FLT3-ITD [Phase 2]
Phase 2 trial update investigating the combination of Quizartinib and Omacetaxine Mepesuccinate for AML with FLT3-ITD mutation.
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: Pharmacokinetics of Micafungin Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease [Phase 2]
Phase 2 trial update comparing twice-weekly intravenous micafungin pharmacokinetics to daily dosing in patients at risk for invasive fungal …
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: Clofarabine Combinations in Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) and Myeloid Blast Phase Chronic Myeloid Leukemia (CML) [Phase 2]
Phase 2 trial update of clo farabine combinations in relapsed/refractory AML and MDS (and myeloid blast phase CML) with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-27Clinical Trial Update: QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML [Phase 2]
Phase 2 trial update for haploidentical NK cells with ALT-803 in adults with relapsed or refractory acute myeloid leukemia has completed wit…
-
CLINICAL_TRIALS trial_result · 2020-11-24Clinical Trial Update: Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy [Phase 2]
Phase 2 trial evaluating eltrombopag olamine to improve platelet recovery in older patients with acute myeloid leukemia undergoing chemother…
-
CLINICAL_TRIALS trial_result · 2020-11-20Clinical Trial Update: Personalized Targeted Preparative Regimen Before T-depleted Allogeneic HSCT in Children With Chemoresistent Acute Leukemias [Phase 3]
Phase 3 trial evaluating a personalized preparative regimen prior to T-depleted allogeneic HSCT in children with chemoresistant acute leukem…
-
CLINICAL_TRIALS trial_result · 2020-11-17Clinical Trial Update: Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia [Phase 2]
Phase II study of bexarotene in Acute Myeloid Leukemia was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-11-06Clinical Trial Update: Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission [Phase 3]
Phase 3 trial results evaluating maintenance therapy with oral azacitidine plus best supportive care in adults with acute myeloid leukemia w…
-
CLINICAL_TRIALS trial_result · 2020-10-29Clinical Trial Update: Pevonedistat and Azacitidine as Maintenance Therapy After Allogeneic Stem Cell Transplantation for Non-Remission AML [Phase 2]
Phase 2 trial evaluating pevonedistat plus azacitidine as maintenance therapy after allogeneic stem cell transplantation in non-remission ac…
-
CLINICAL_TRIALS trial_result · 2020-10-28Clinical Trial Update: Study of Vosaroxin With Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2 [Phase 2]
Phase 2 trial evaluating vosaroxin with azacitidine for newly diagnosed acute myeloid leukemia or Myelodysplastic Syndrome with excess blast…
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Avelumab and Azacitidine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia [Phase 1, Phase 2]
Clinical trial evaluating avelumab plus azacitidine for refractory or relapsed acute myeloid leukemia (AML) arising from prior myelodysplast…
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: NK Cell Therapy Recurrent/Refractory Elderly AML [Phase 1, Phase 2]
Clinical trial update for NK cell therapy in recurrent/refractory elderly AML spanning Phase 1 and Phase 2.